Suppr超能文献

[减敏治疗的机制与新进展]

[Mechanisms and new innovations in hyposensitization].

作者信息

Savolainen Johannes, Alenius Harri, Renkonen Risto

机构信息

Turun yliopisto, kliininen laitos ja TYKS:n allergiayksikkö, PL 52, 20521 Turku.

出版信息

Duodecim. 2011;127(12):1289-95.

Abstract

According to established view, the underlying factor in allergic immune response is imbalance between the number and function of allergen-specific CD4+ lymphocytes. In atopic allergy, type 2 helper T lymphocytes (Th2 cells) are elevated in relation to regulatory T lymphocytes (Treg cells). In healthy subjects the ratio is vice versa. It seems that tolerance generated through allergen-specific Treg cells is the immunologic reaction mode towards allergens in healthy non-atopic subjects. It has been found that hyposensitization will correct the imbalance of Th2 and Treg cells and restore the normal immune response to allergens.

摘要

根据既定观点,过敏性免疫反应的潜在因素是过敏原特异性CD4+淋巴细胞数量与功能之间的失衡。在特应性过敏中,2型辅助性T淋巴细胞(Th2细胞)相对于调节性T淋巴细胞(Treg细胞)数量增加。在健康受试者中,比例则相反。似乎通过过敏原特异性Treg细胞产生的耐受性是健康非特应性受试者对过敏原的免疫反应模式。已经发现,减敏疗法将纠正Th2和Treg细胞的失衡,并恢复对过敏原的正常免疫反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验